Arrhythmias & electrophysiology

Study protocol for The Heart Watch Study - Prognostic performance of smartwatch 12-lead electrocardiography (ECG) with advanced ECG analysis in consumer self-screening for cardiovascular disease

Am Heart JPublished prospective, Australia-wide observational cohort study

Study context

Population
Asymptomatic adults aged 20–79 years without prior known cardiovascular disease performing consumer self-screening in the general populationplanned recruitment
Participants
30,000 adults
Planned comparison
Advanced ECG (A-ECG) analysis applied to a smartwatch 12-lead ECG (SWECG) acquired using an Apple Watch in identifying cardiovascular risks
Methodological detailsstudy protocol
  • Study protocol

No results yet. This paper sets out the design of a trial; its results are to come.

Original publication

Study protocol for The Heart Watch Study - Prognostic performance of smartwatch 12-lead ECG with advanced ECG analysis in consumer self-screening for cardiovascular disease. Am Heart J. Published 29 September 2026. doi:10.1016/j.ahj.2026.107619

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.